Why it was recalled
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
Product description
Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.
Lot numbers, UPCs & expiration codes
Lot PZFDE06, Exp 08/31/2025
Where it was sold
NC, SC, VA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0393-2025
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Apr 9, 2025
- FDA report date
- May 7, 2025
- Quantity
- 48 Cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Cardinal Health Inc.
Original FDA data
Every field from FDA enforcement report D-0393-2025, exactly as published.
Show all FDA fields
- City
- Dublin
- State
- OH
- Status
- Ongoing
- Country
- United States
- Event ID
- 96637
- Address
- 7000 Cardinal Pl
- Code information
- Lot PZFDE06, Exp 08/31/2025
- Postal code
- 43017-1091
- Report date
- May 7, 2025
- Product type
- Drugs
- Recall number
- D-0393-2025
- Classification
- Class II
- Recalling firm
- Cardinal Health Inc.
- Product quantity
- 48 Cartons
- Reason for recall
- Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.
- Distribution pattern
- NC, SC, VA
- Recall initiation date
- Apr 9, 2025
- Initial firm notification
- Letter
- Center classification date
- Apr 28, 2025